Table 4 Factors associated with early PEG insertion in multiple linear regression analysis (n = 188).

From: Timing and impact of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis: a comprehensive analysis

 

B

SE

β

t

p

VIF

Age at diagnosis

− 0.681

0.107

− 0.337

− 6.381

 < 0.001

1.226

Bulbar Onset

− 5.795

2.243

− 0.134

− 2.584

0.011

1.181

Time from symptom onset to diagnosis

1.229

0.134

0.603

9.216

 < .001

1.886

BMI at diagnosis

− 0.125

0.322

− 0.019

− 0.387

0.699

1.084

ALSFRS-R at diagnosis

0.535

0.248

0.138

2.157

0.032

1.787

Weight loss at severe dysphagia

0.189

0.109

0.093

1.730

0.085

1.281

Rate of decline

 From onset to diagnosisa

0.178

1.293

0.009

0.138

0.891

1.859

 From diagnosis to weight loss 10%b

− 1.924

1.102

− 0.109

− 1.746

0.083

1.726

 From diagnosis to swallowing F2c

− 3.915

1.234

− 0.199

− 3.171

0.002

1.733

  1. B, unstandardized regression coefficient; SE, standard error; β, standardized regression coefficient; VIF, variance inflation factor, PEG, percutaneous endoscopic gastrostomy; BMI, body mass index; ALSFRS-R, amyotrophic lateral sclerosis functional rating scale-revised; swallowing F2:the timepoint when the patients get 2 points on ALSFRS-R question 3.
  2. aRate of decline from onset to diagnosis was calculated using the following formula: Rate of decline = (48—ALSFRS-R score at the time of diagnosis)/duration from symptom onset to the time of diagnosis (months). bRate of decline from diagnosis to weight loss 10% was calculated using the following formula: Rate of decline = (ALSFRS-R score at the time of diagnosis—ALSFRS-R score at the time of 10% weight loss)/duration from diagnosis to the time of the 10% weight loss (months). cRate of decline from diagnosis to swallowing F2 was calculated using the following formula: Rate of decline = (ALSFRS-R score at the time of swallowing F2—ALSFRS-R score at the time of PEG)/duration from swallowing F2 to the time of PEG (months).